Rein Therapeutics, Inc. (RNTX) Insider Trading

Name: Rein Therapeutics, Inc. (RNTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (May 29, 2026): Rickenbach Josef H. Von (Director): Purchase of 3,420 shares, $3.6K.

Get alerted when insiders trade RNTX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta